Metformin has a therapeutic effect, confirmed in an animal model of systemic lupus erythematosus (SLE) through mechanisms involving the inhibition of oxidative phosphorylation (OXPHOS) and the diminishment of CD4+ T cell activation. This evidence concerns the gene CD4 and systemic lupus erythematosus.